Valaciclovir for the suppression of recurrent genital HSV infection: A placebo controlled study of once daily therapy

Genitourinary Medicine

Volumn 73, Issue 2, 1997, Pages 105-109

  Patel, R ^a   Bodsworth, N J ^b   Woolley, P ^c   Peters, B ^d   Vejlsgaard, G ^e   Saari, S ^f   Gibb, A ^g   Robinson, J ^a  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^b Taylor Square Private Clinic ^*  (Australia)

^c WITHINGTON HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e Rigshospitalet   (Denmark)

^f Laakariasema Pulssi   (Finland)

^g GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Herpes simplex virus; Suppression; Valaciclovir

Indexed keywords

PLACEBO; VALACICLOVIR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENITAL HERPES; HEADACHE; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ACYCLOVIR; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HERPES GENITALIS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; VALINE;

EID: 79960404300     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nahmias AJ, Lee FK, Beckman-Nahmias S. Seroepidemiological and sociological patterns of herpes virus infection in the world. Scand J Infect Dis Suppl 1990;69:19-36.
2. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiological survey of the prevalence of herpes simpex virus type-2 infection in the United States. N Engl J Med 1989;321:7-12.
3. Corey L. The current trend in genital herpes. Sex Transm Dis 1994; Suppl 2: S38-44.
4. Mertz GJ. Herpes simplex virus. In: Galasso GJ, Whitley RJ, Merigan TC, eds. Antiviral agents and viral diseases of man. 3rd ed. New York: Raven Press, 1990.
5. Kinghorn GR. Genital herpes: natural history and treatment of acute episodes. J Med Virol 1993;Suppl 1:33-8.
6. Corey L. Genital herpes. In: Holmes KK, Mardh PA, Sparling PF, Weisner PJ, eds Sexually transmitted diseases. Part 5 Sexually transmitted agents. New York: McGraw-Hill, 1990.
7. Wagstaff AJ, Faulds D, Goa KL. Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:153-205.
8. Whitley RJ, Gnaan JW. Acyclovir: a decade later. N Engl J Med 1992;327:782-9.
9. Carney O, Ross E, Ikkos G, Mindel A. The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes. Genitourin Med 1993;69:457-9.
10. Kinghorn GR. Long-term suppression with oral acyclovir of recurrent herpes simplex virus infections in otherwise healthy patients. Am J Med 1988;85 (Suppl 2A):26-9.
11. Straus SE, Croen KD, Sawyer MH, Freifeld AG, Felser JM, Dale JK, et al. Acyclovir suppression of frequently recurring genital herpes. JAMA 1988;260:2227-30.
12. Kroon S, Petersen CS, Andersen LP, Ronne Rasmussen J, Vestergaard BF. Oral acyclovir suppressive therapy in severe recurrent genital herpes. Dan Med Bull 1989;36:298-300.
13. Mertz GJ, Jones CC, Mills J, Fife KH, Lemon SM, Stapleton JT, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. JAMA 1988;260:201-6.
14. Mattison HR, Reichman RC, Benedetti J, Bolgiano D, Davis LG, Bailey-Farchione A, et al. Double-blind placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am J Med 1988;85 (suppl 2A):20-5.
15. Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984;310:1551-6.
16. Tilson HH, Engle CR, Andrews EB. Safety of aciclovir: a summary of the first 10 years' experience. J Med Virol 1993;1:67-73.
17. Baker DA, Safrin S, Deeter RG, Walker A, Barton G, and the Acyclovir Study Group. Nine year effectiveness of continuous suppressive therapy with acyclovir (ACV) in patients with recurrent genital herpes (RGH). J Eur Acad Dermatol Venereol 1995;5 (Suppl 1): S169.
18. Mindel A, Carney O, Freris M, Faherty A, Patou G, Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988;i:926-8.
19. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przyback TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
20. Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, et al. Pharmacokinetics of the aciclovir prodrug valaciclovir after single- and multiple-dose administration in normal volunteers. Clin Pharmacol Exp Ther 1993;54:595-605.
21. Soul-Lawton S, Seaber E, On N, Wootton R, Rolan P, Posner J, et al. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of aciclovir, following oral administration to humans. Antimicrob Agents Chemother 1995;39:2759-64.
22. Spruance SL, Tyring SK, Degregorio B, Miller C, Beutner K, and the Valaciclovir Study Group. A large scale placebo-controlled trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996;156:1729-35.
23. Kinghorn GI, Fiddian AP, and the Valaciclovir International HSV Study Group. Prevention of lesion development in recurrent genital herpes with oral valaciclovir. J Eur Acad Dermatol Venereol 1995;5:S162.
24. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982;1:121-9.
25. Goldberg LH. Oral acyclovir for episodic treatment of recurrent genital herpes: efficacy and safety. J Am Acad Dermatol 1986;15:256-64.
26. Huff JC, Bean B, Balfour HH Jr, Laskin OL, Connor JD, Corey L, et al. Therapy for herpes zoster with oral acyclovir. Am J Med 1988;85:84-9.
27. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. NZ Med J 1989;102:93-5.
28. Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988;85:79-83.
29. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy of herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39:1546-53.